Glazer Capital LLC’s Drugs Made In America Acquisition Corp. Rights DMAAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$156K Hold
1,300,000
0.01% 170
2025
Q1
$169K Buy
+1,300,000
New +$169K 0.01% 135